EXCLUSIVE: Gabby Agbonlahor tells Eden Hazard to retire after being 'Real Madrid's biggest flop'
That's the view of talkSPORT's Gabby Agbonlahor, who believes the former2Credit: getty
The ex-Aston Villa striker was playing a game of 'Destination Unknown' on Tuesday's Breakfast show with co-host Natalie Sawyer, which involves giving his take on what some of football's free agents should do this summer.Real MadridHowever, Hazard's career with Los Blancos never really got going and he made just 76 appearances in four years thanks to a wide range of injury problems.
These issues resulted in him never recovering his previous form and he scored only seven goals, leading to his contract being rescinded a year early.Hazard now has the chance for a fresh start but Agbonlahor doesn't believe he should continue and should end his playing career instead. "I would retire if I'm Eden Hazard," Agbonlahor explained. "I feel like you're probably going to go down as one of the biggest flops of Real Madrid's history.But Agbonlahor then said he wasn't sure it was just his fitness that played a role in his unsuccessful spell in Madrid.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
'One of the biggest flops of all-time' - Eden Hazard to to retire by Gabby AgbonlahorEden Hazard should hang up his boots following his exit from Real Madrid. That’s the view of talkSPORT’s Gabby Agbonlahor, who believes the former Chelsea man should cut his losses and …
Weiterlesen »
Agbonlahor cries 'I'm younger than Ronaldo' in Al Ettifaq plea to GerrardtalkSPORT’s Gabby Agbonlahor issued a hilarious plea for Steven Gerrard to sign him up at Al Ettifaq. The Liverpool legend’s appointment at the Saudi Arabian side was confirmed on Monda…
Weiterlesen »
Londonderry: Derry Eden Project plans to be 'reconsidered'Plans for the Eden Project Foyle are being reconsidered, the team behind the multimillion-pound project in Londonderry has said
Weiterlesen »
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing - BMC BioinformaticsPathway-level survival analysis offers the opportunity to examine molecular pathways and immune signatures that influence patient outcomes. However, available survival analysis algorithms are limited in pathway-level function and lack a streamlined analytical process. Here we present a comprehensive pathway-level survival analysis suite, PATH-SURVEYOR, which includes a Shiny user interface with extensive features for systematic exploration of pathways and covariates in a Cox proportional-hazard model. Moreover, our framework offers an integrative strategy for performing Hazard Ratio ranked Gene Set Enrichment Analysis and pathway clustering. As an example, we applied our tool in a combined cohort of melanoma patients treated with checkpoint inhibition (ICI) and identified several immune populations and biomarkers predictive of ICI efficacy. We also analyzed gene expression data of pediatric acute myeloid leukemia (AML) and performed an inverse association of drug targets with the patient’s clinical endpoint. Our analysis derived several drug targets in high-risk KMT2A-fusion-positive patients, which were then validated in AML cell lines in the Genomics of Drug Sensitivity database. Altogether, the tool offers a comprehensive suite for pathway-level survival analysis and a user interface for exploring drug targets, molecular features, and immune populations at different resolutions.
Weiterlesen »
Wildfire smoke exposure and early childhood respiratory health: a study of prescription claims data - Environmental HealthWildfire smoke is associated with short-term respiratory outcomes including asthma exacerbation in children. As investigations into developmental wildfire smoke exposure on children’s longer-term respiratory health are sparse, we investigated associations between developmental wildfire smoke exposure and first use of respiratory medications. Prescription claims from IBM MarketScan Commercial Claims and Encounters database were linked with wildfire smoke plume data from NASA satellites based on Metropolitan Statistical Area (MSA). A retrospective cohort of live infants (2010–2016) born into MSAs in six western states (U.S.A.), having prescription insurance, and whose birthdate was estimable from claims data was constructed (N = 184,703); of these, gestational age was estimated for 113,154 infants. The residential MSA, gestational age, and birthdate were used to estimate average weekly smoke exposure days (smoke-day) for each developmental period: three trimesters, and two sequential 12-week periods post-birth. Medications treating respiratory tract inflammation were classified using active ingredient and mode of administration into three categories:: 'upper respiratory', 'lower respiratory', 'systemic anti-inflammatory'. To evaluate associations between wildfire smoke exposure and medication usage, Cox models associating smoke-days with first observed prescription of each medication category were adjusted for infant sex, birth-season, and birthyear with a random intercept for MSA. Smoke exposure during postnatal periods was associated with earlier first use of upper respiratory medications (1–12 weeks: hazard ratio (HR) = 1.094 per 1-day increase in average weekly smoke-day, 95%CI: (1.005,1.191); 13–24 weeks: HR = 1.108, 95%CI: (1.016,1.209)). Protective associations were observed during gestational windows for both lower respiratory and systemic anti-inflammatory medications; it is possible that these associations may be a consequence of live-birth bias. These findi
Weiterlesen »